# Kyoto Capital Partners

> Kyoto Capital Partners is a VC fund in Kyoto backing Health Care and Manufacturing. See 39 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Kyoto, Japan
- Total investments: 39
- Last investment: Jun 2026
- Lead investor: 8%
- Last updated: Aug 2026

Kyoto Capital Partners is an investment company affiliated with the Bank of Kyoto.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $102k–$2.9M |
| Series A | $955k–$29M |
| Series B | $1.2M–$16M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 9 | 23% |
| Manufacturing | 8 | 21% |
| Medical | 6 | 15% |
| Consulting | 5 | 13% |
| Artificial Intelligence | 5 | 13% |

71 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 10 | 26% |
| Series A | 9 | 23% |
| Series B | 9 | 23% |
| Funding Round | 3 | 8% |
| Venture - Series Unknown | 3 | 8% |

8 stages tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Serendip Consulting | Serendip Consulting refers to business portfolio optimization and provision of effective solutions.The Serendip Group operates not only strategic and financial consulting, but also a business company with a focus on manufacturing. Aiming for further growth of the entire group by restructuring the "business portfolio" based on the know-howof nurturing small and medium-sized businesses cultivated over 10 years since its foundation and investment experience, and "modernizing management" by dispatching professional managers You. | $15.5M | Post-IPO Equity | Jun 21, 2026 |  |
| Monozukuri Business Succession Holdings (JMS) | Monozukuri Business Succession Holdings is a specialized corporate investment subsidiary. The platform modernizes mid-sized manufacturing firms facing generational leadership transitions. Strategic institutional banking partnerships protect public shareholder equity from dilution. After acquisition, the firm installs professional management andautomated factory systems. All operational yields consolidate into the parent organization to drive long-term growth. | $12.5M | Venture - Series Unknown | Jun 01, 2026 |  |
| Scohia Pharma | Scohia Pharma is a biotech venture that will have both substantial research and development resources and be nimble enough to make decisions quickly, will strive to improve patient quality of life by providing patients and healthcare professionals with new therapeutic medications for renal, metabolic. | $442.5M |  | May 28, 2026 |  |
| YStory | YStory is a digital health firm that uses AI and medical science to improve women's health during menopause. |  | Seed | Apr 27, 2026 |  |
| BALLAS | BALLAS provides corporate information, business content, procurement of construction materials, custom-made construction materials used at construction sites online, design, development, manufacturing, and sales of construction materials. | $13.2M | Series B | Apr 15, 2026 |  |
| RECOTECH | RECOTECH is a ClimateTech firm that collects and shares data to maximize resource value throughout its life cycle, offering circular solutions to organizations and municipalities in Japan and beyond. |  | Series A | Feb 27, 2026 |  |
| CI Partners | CI Partners mission is to "eliminate the word 'disability' from this country," and with the message "Everyone is a star." | $2.6M | Series B | Dec 18, 2025 |  |
| LEP | LEP develops plants that glow without electricity. | $1M | Seed | Dec 16, 2025 |  |
| Aba | Aba develops products that reduce the burden of nursing care. Aba company has developed a device that can detect and record the excretion status of the care recipient, aiming to solve the mental and physical burden of the carer / care recipient by excretion sensing and pattern analysis. |  | Venture - Series Unknown | Dec 01, 2025 |  |
| SecureNavi | SecureNavi offers automation tools for the information security management system. It reduces conventional analogue operations using excel and word. For inquiries, telephone numbers and physical addresses are available on their website. | $7.8M | Series B | Nov 06, 2025 |  |

10 of 39 investments shown.

## Co-investors
- [Global Brain Corporation](https://shizune.co/investors/profile/global-brain-corporation) — VC Fund, 10 deals together
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund, 9 deals together
- [Kyoto University Innovation Capital](https://shizune.co/investors/profile/kyoto-university-innovation-capital) — VC Fund, 7 deals together
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund, 6 deals together
- [SBI Investment](https://shizune.co/investors/profile/sbi-investment-2) — VC Fund, 5 deals together
- [Seiho Investment Works](https://shizune.co/investors/profile/seiho-investment-works) — VC Fund, 5 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Breakthrough Energy Ventures](https://shizune.co/investors/profile/breakthrough-energy-ventures) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Mitsubishi UFJ Capital](https://shizune.co/investors/profile/mitsubishi-ufj-capital) — VC Fund
- [SMBC Venture Capital](https://shizune.co/investors/profile/smbc-venture-capital) — VC Fund
- [Mizuho Capital](https://shizune.co/investors/profile/mizuho-capital) — VC Fund

## Featured in investor lists
- [Climate Investors in Japan](https://shizune.co/investors/climate-investors-japan)
- [Energy Investors in Japan](https://shizune.co/investors/energy-investors-japan)
- [Energy VC Funds in Japan](https://shizune.co/investors/energy-vc-funds-japan)
- [Sustainability VC Funds in Japan](https://shizune.co/investors/sustainability-vc-funds-japan)
- [Impact VC Funds in Japan](https://shizune.co/investors/impact-vc-funds-japan)
- [Health Care Investors in Japan](https://shizune.co/investors/health-care-investors-japan)

## FAQ

### What does Kyoto Capital Partners invest in?

Kyoto Capital Partners invests primarily in Health Care, Manufacturing and Medical startups, most often at Seed and Series A stage. Most of the 39 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Kyoto Capital Partners's check size?

Kyoto Capital Partners typically joins rounds of $102k–$2.9M at Seed, $955k–$29M at Series A and $1.2M–$16M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Kyoto Capital Partners participates in.

### When did Kyoto Capital Partners last invest?

The most recent investment recorded for Kyoto Capital Partners closed in Jun 2026. Shizune tracks 39 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co